How Much Weight Per Week Do You Lose on Wegovy?

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy (semaglutide) has become one of the most prescribed GLP-1 medications for weight loss, with clinical trials showing participants lost an average of 15% of their body weight over 68 weeks. However, weekly weight loss rates vary significantly from person to person, and understanding what to expect can help you set realistic goals and stay motivated throughout your treatment.

Typical Weekly Weight Loss Rate on Semaglutide

Once semaglutide reaches its therapeutic dose—typically 2.4 mg weekly—most people experience weight loss of 1 to 3 pounds per week during the first 6 months of treatment. This rate is notably faster than what most people achieve through diet and exercise alone, which usually results in 0.5 to 1 pound per week. Individual variation is substantial: some people lose weight more steadily while others experience weight plateaus followed by rapid drops. Factors like your starting body weight, metabolic rate, and adherence to healthy eating habits all influence your personal trajectory.

During the first two weeks after starting semaglutide, many people notice rapid water weight loss and appetite suppression, which can feel dramatic but represents initial physiological shifts rather than pure fat loss. As weeks progress into months, the pace may slow but often becomes more consistent, with the majority of clinically meaningful weight loss occurring between weeks 12 and 32 of consistent dosing. Your body's natural set-point resistance and hormonal adaptations mean that extremely high weekly losses typically cannot sustain indefinitely, making steady, sustainable progress preferable to unpredictable spikes.

How Dose Escalation Affects Your Weight Loss Timeline

Semaglutide dosing follows a structured escalation schedule: treatment typically begins at 0.25 mg weekly, then increases to 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mg over 16 weeks. Many people do not experience significant weight loss until their dose reaches 1 mg or higher, meaning dramatic results often begin around week 8–12 of treatment rather than immediately. This gradual approach allows your body to adapt and reduces the intensity of gastrointestinal side effects like nausea, which can interfere with treatment adherence. Your dose may need to go up over time as your body adapts, but your price won't—PlexusDx charges a flat monthly rate regardless of your dose level.

Some people reach their target weight loss at lower doses (1.0–1.7 mg) and choose to remain there rather than advancing to the 2.4 mg maintenance dose. This personalized approach, guided by your healthcare provider, can provide effective results while minimizing side effects and medication cost. Others require the full 2.4 mg dose to achieve meaningful weight reduction, and only response monitoring over weeks can clarify which group you belong to.

Why Individual Results Vary So Dramatically

Genetic predispositions play a significant role in how your body responds to semaglutide, influencing everything from your appetite hormones to your metabolic efficiency. Specific variants in genes like GLP1R, GIPR, and MC4R affect how strongly GLP-1 signaling works in your brain and body, which determines whether you'll see dramatic early weight loss or a more gradual response. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on) to identify your unique peptide pathway profile across 14 metabolic pathways and 150+ genetic insights, helping predict which GLP-1 approach may work best for your biology.

Beyond genetics, your starting weight matters greatly: someone beginning at 350 pounds often loses more total weight per week than someone starting at 200 pounds, partly because larger bodies require more energy to maintain. Your diet quality, physical activity level, sleep patterns, stress management, and any underlying metabolic conditions (like thyroid disorder or polycystic ovary syndrome) all modulate the speed and magnitude of weight loss. Additionally, previous experience with weight-loss medications or yo-yo dieting can affect how quickly your metabolism responds to semaglutide's appetite-suppressing and metabolic effects.

Setting Realistic Expectations and Sustaining Long-Term Success

Rather than fixating on weekly weight loss numbers, healthcare providers recommend tracking progress over monthly and quarterly intervals, which smooth out the natural fluctuations caused by water retention, menstrual cycles, and normal metabolic variation. Most people who commit to semaglutide treatment lose 10–15% of their starting body weight within 6 months, with some exceeding 20% weight loss by the one-year mark, depending on baseline weight and lifestyle adherence. Weight loss typically plateaus around 12–18 months of consistent treatment, at which point the goal shifts to weight maintenance and preventing rebound gain.

Success on semaglutide extends beyond the number on the scale: blood sugar control improves, blood pressure often decreases, and joint stress diminishes—all meaningful health gains even if weekly weight loss slows. PlexusDx provides ongoing support through licensed 503A compounding pharmacies across all 50 states, with treatment starting at $149/month for compounded semaglutide injection, HSA/FSA eligibility, and no insurance requirement, making consistent access to personalized therapy affordable and sustainable.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is it normal to lose only 1 pound per week on Wegovy instead of 2 or 3?

Yes, weekly loss of 1 pound is completely normal and represents about 3,500 calories of fat loss, which is actually excellent progress. Individual variation is expected, and slower, steady weight loss often correlates with better long-term maintenance and fewer side effects than rapid drops. Your healthcare provider can help assess whether your current dose is optimal or if other factors (diet, sleep, stress) need adjustment.

What clinical trial data supports the weekly weight loss claims for semaglutide?

The STEP 1 trial showed participants on semaglutide 2.4 mg lost an average of 9.3% of body weight over 68 weeks (approximately 1–2 pounds per week during the active phase), compared to 2.6% loss in the placebo group. Participants with higher starting weights often saw total losses exceeding 20% by the end of the trial. These results represent real-world outcomes in people with overweight or obesity who combined medication with lifestyle modification.

How does PlexusDx pricing work if my dose increases over time?

PlexusDx charges a flat monthly rate for semaglutide injection starting at $149/month, regardless of whether your dose goes from 0.25 mg to the full 2.4 mg therapeutic level. Your dose may need to go up—your price won't. Treatment is available across all 50 states with no insurance requirement and HSA/FSA eligibility.

Can side effects slow down my weight loss progress?

Yes—nausea, constipation, or reduced food tolerance can interfere with nutritional intake and energy for physical activity, which may temporarily plateau weight loss. These side effects typically improve over 1–2 weeks as your body acclimates to each dose increase, and slower dose escalation can minimize them. If side effects persist, your provider may adjust your dosing schedule or recommend supportive measures.

How can the Precision Peptide Genetic Test help predict my weight loss on semaglutide?

The Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, MC4R, and FTO genes that influence your appetite signaling and metabolic efficiency, helping predict whether you'll respond robustly to GLP-1 therapy. This $99 add-on test maps 14 metabolic pathways and 150+ genetic insights, allowing PlexusDx to personalize your treatment approach and potentially select between semaglutide, tirzepatide, or combination therapy based on your biology.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Wegovy For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.